Matrix metalloproteinase-3 (MMP-3) in synovial fluid with temporomandibular joint disorders
暂无分享,去创建一个
M. Nakajima | K. Kakudo | A. Kamada | T. Ikeo | J. Okazaki | Y. Komasa | T. Arika | M. Gotoh
[1] S. Fujita,et al. The localization of matrix metalloproteinase-3 and tenascin in synovial membrane of the temporomandibular joint with internal derangement. , 2008, Oral diseases.
[2] Michael F. G. Schmidt,et al. Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis. , 2003, Veterinary immunology and immunopathology.
[3] L. Brunnberg,et al. Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. , 2002, Osteoarthritis and cartilage.
[4] V. Pistoia,et al. Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritides. , 2002, The Journal of rheumatology.
[5] A. Poole,et al. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. , 2001, Arthritis and rheumatism.
[6] D. Woolley,et al. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. , 2001, Arthritis and rheumatism.
[7] M. Malaise,et al. Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. , 2000, Rheumatology.
[8] P. R. Weeren,et al. Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid , 2000, Annals of the rheumatic diseases.
[9] Y. Mikuni‐Takagaki,et al. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder. , 1998, European journal of oral sciences.
[10] R. Moskowitz,et al. Increased secretion and activity of matrix metalloproteinase-3 in synovial tissues and chondrocytes from experimental osteoarthritis. , 1998, Osteoarthritis and cartilage.
[11] E. Kubota,et al. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. , 1998, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[12] S. Kopp,et al. Interleukin-1beta in plasma and synovial fluid in relation to radiographic changes in arthritic temporomandibular joints. , 1998, European journal of oral sciences.
[13] K. Kakudo,et al. Chondroitin sulfate isomers in synovial fluid of healthy and diseased human temporomandibular joints. , 1997, European journal of oral sciences.
[14] B. Henderson,et al. The role of oxygen free radicals in idiopathic facial pain. , 1997, The British journal of oral & maxillofacial surgery.
[15] G. Murphy,et al. Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? , 1997, Matrix biology : journal of the International Society for Matrix Biology.
[16] D. Hamblen,et al. Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. , 1995, Annals of the rheumatic diseases.
[17] D. Taylor,et al. Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity. , 1994, Annals of the rheumatic diseases.
[18] P. Roughley,et al. Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. , 1993, Matrix.
[19] Y. Okada,et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. , 1992, Clinica chimica acta; international journal of clinical chemistry.
[20] H. Roos,et al. Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine. , 1992, Clinical biochemistry.
[21] A. Kang,et al. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. , 1990, Arthritis and rheumatism.
[22] J. Pelletier,et al. The role of cytokines in osteoarthritis pathophysiology. , 2002, Biorheology.
[23] A. Nagano,et al. Levels of Rheumatoid Factor Isotypes, Metalloproteinase-3 and Tissue Inhibitor of Metalloproteinase-1 in Synovial Fluid from Various Arthritides , 2000, Clinical Rheumatology.
[24] A. Roessner,et al. Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. , 1998, Pathology, research and practice.